查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
南美洲和中美洲放射性示踪劑市場預測至 2030 年 - 區域分析 - 按示踪劑類型、測試類型、應用和最終用戶
市場調查報告書
商品編碼
1420161

南美洲和中美洲放射性示踪劑市場預測至 2030 年 - 區域分析 - 按示踪劑類型、測試類型、應用和最終用戶

South & Central America Radioactive Tracer Market Forecast to 2030 - Regional Analysis - by Tracer Type, Test Type, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 113 Pages | 訂單完成後即時交付

價格

2022年，南美洲和中美洲放射性示蹤劑市值為4.7696億美元，預計2030年將達到16.3433億美元；預計2022年至2030年CAGR為16.6%。

放射性示蹤劑在癌症診斷中的使用推動了南美洲和中美洲放射性示蹤劑市場

隨著全球癌症病例不斷增加，腫瘤學是醫療保健領域顯著發展的領域。根據健康指標與評估研究所 (IHME) 的數據，癌症是繼心血管疾病之後的第二大死因。隨著腫瘤學的顯著發展，先進材料和藥物在癌症診斷和治療中的使用激增。基於放射性追蹤劑的影像是用於準確診斷癌症類型（例如前列腺癌、婦科癌症和血液傳染癌症）的先進診斷方法之一。一旦注射到體內，這些放射性追蹤劑就會附著在癌症特定部位，從而準確診斷癌症類型。示蹤劑還有助於確定癌症的發展階段，在大多數情況下實現有效的治療和更快的恢復。 PET 和 SPECT 屬於使用伽瑪發射器檢測腫瘤的核子造影技術。隨著腫瘤的生長，其對 PET 和 SPECT 結合物的吸收隨著時間的推移而增加，由於核成像劑的存在而提高了對比度。這進一步導致血液清除，由此可以產生清晰的診斷影像。用於檢測癌症的最常用放射性追蹤劑是 F-18 氟脫氧葡萄糖 (18F-FDG)，一種類似葡萄糖或糖的化合物。癌細胞高度活躍，比正常細胞需要更多的能量，即額外的葡萄糖。 PET 或 SPECT 等影像設備可偵測 FDG 釋放的能量，以建立顯示放射性追蹤劑在體內位置的影像。這有助於確定癌細胞在患者體內的位置，以便根據癌症的類型和階段製定治療方案。因此，在癌症診斷中擴大使用放射性示蹤劑預計將在預計的時間內推動市場擴張。

南美洲和中美洲放射性示蹤劑市場概述

南美洲和中美洲放射性示蹤劑市場分為巴西、阿根廷以及南美洲和中美洲其他地區。由於癌症病例數量不斷增加、政府措施不斷增加以及放射性示蹤劑的研發不斷增加，預計該地區的市場將會成長。

南美洲和中美洲放射性示蹤劑市場收入和 2030 年預測（百萬美元）

南美洲和中美洲放射性示蹤劑市場細分

南美洲和中美洲放射性示蹤劑市場根據示蹤劑類型、測試類型、最終用戶、應用和國家進行細分。根據示蹤劑類型，南美洲和中美洲放射性示蹤劑市場分為锝-99m和Tc-97m、碘-131、鐵-59、镥-171、氯化銣(Rb-82) 和氨(N -13) , 鈧-46、鈧-269、 哈西姆-269、檸檬酸鎵Ga 67、前列腺特異性膜抗原(PSMA) (Ga-68)、 FDDNP (F-18) 和FDOPA (F-18 )、 磷-32 和鉻-51、鉈-201、F-18 FDG、F-18 FAPI、Ga-68 FAPI、F-18 PSMA、DOTATOC/DOTANOC/DOTATATE (Ga-68) 等。 2022 年，其他細分市場佔據最大市場佔有率。

根據測試類型，南美洲和中美洲放射性追蹤劑市場分為 PET、SPECT 等。 2022 年，PET 細分市場佔據最大的市場佔有率。

根據最終用戶，南美洲和中美洲放射性示蹤劑市場分為醫院和診所、診斷中心、學術和研究機構等。 2022 年，醫院和診所細分市場佔據最大的市場。

根據應用，南美洲和中美洲放射性示蹤劑市場分為腫瘤學、肺病學、神經病學、心臟病學等。 2022 年，腫瘤學領域佔據最大的市場。

根據國家/地區，南美洲和中美洲放射性示蹤劑市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2022 年，南美洲和中美洲其他地區主導了南美洲和中美洲放射性示蹤劑市場。

Rotem Industries Ltd、Invicro LLC、Cardinal Health Inc、紐卡斯爾大學、諾華公司、Curium 和 IBA Radiopharma Solutions 是南美洲和中美洲放射性示踪劑市場的一些領先參與者。

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲放射性示蹤劑市場 - 主要產業動態

  • 主要市場促進因素：
    • 慢性病盛行率上升
    • 擴大使用核子成像技術
  • 市場限制
    • 放射性示蹤劑的保存期限短
    • 核診斷影像程序替代品的可用性
  • 市場機會
    • 新興經濟體的存在與人口的成長
    • 用於標靶治療的個人化放射性藥物的開發
  • 未來的趨勢
    • 放射性示蹤劑在癌症診斷的應用
  • 影響分析：

第 5 章：放射性示蹤劑市場 - 南美洲和中美洲市場分析

  • 放射性示蹤劑市場收入，2022 - 2030

第 6 章：南美洲和中美洲放射性示蹤劑市場 - 2030 年收入和預測 - 按下示蹤劑類型

  • 概述
  • 2022 年及 2030 年放射性示蹤劑市場收入佔有率，依示蹤劑類型分類 (%)
  • 锝 99m 和 TC-97m
  • 碘131
  • 鐵59
  • 镥- 171
  • RB82和氨N-13
  • 鈧46
  • ?-269
  • 哈西姆-269
  • 檸檬酸鎵 GA 67
  • PSMA GA68
  • FDDNP (F-18) 和 FDOPA (f-18)
  • 磷 32 和鉻 -51
  • 鉈201
  • F-18 FDG
  • F-18 FAPI
  • GA 68 FAPI
  • F-18 PSMA
  • DOTATOC/DOTANOC/DOTATATE Ga 68
  • 其他

第 7 章：南美洲和中美洲放射性示蹤劑市場 - 2030 年收入和預測 - 按測試類型

  • 概述
  • 2022 年及 2030 年按測試類型分類的放射性示蹤劑市場收入佔有率 (%)
  • 寵物
  • SPECT
  • 其他

第 8 章：南美洲和中美洲放射性示蹤劑市場 - 2030 年收入和預測 -按應用。

  • 概述
  • 2022 年和 2030 年按應用分類的放射性示蹤劑市場收入佔有率 (%)
  • 腫瘤學
  • 肺部
  • 神經病學
  • 心臟病學
  • 其他

第 9 章：南美洲和中美洲放射性示蹤劑市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年及 2030 年最終用戶放射性示蹤劑市場收入佔有率 (%)
  • 醫院和診所
  • 診斷中心
  • 學術及研究機構
  • 其他

第 10 章：南美洲和中美洲放射性示蹤劑市場 - 國家分析

    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：放射性示蹤劑市場產業格局

  • 概述
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 12 章：放射性示蹤劑市場，主要公司概況

  • Rotem Industries Ltd
  • Invicro LLC
  • Cardinal Health Inc
  • Newcastle University
  • Novartis AG
  • Curium
  • General Electric Co
  • IBA Radiopharma Solutions

第 13 章：附錄

  • 關於我們
  • 專業術語
Product Code: BMIRE00029123

The South & Central America radioactive tracer market was valued at US$ 476.96 million in 2022 and is expected to reach US$ 1,634.33 million by 2030; it is estimated to grow at a CAGR of 16.6% from 2022 to 2030.

Use of Radioactive Tracer in Cancer Diagnosis fuel the South & Central America Radioactive Tracer Market

Oncology is a significantly developing field in the healthcare sector, as cancer cases are increasing worldwide. According to Institute for Health Metrics and Evaluation (IHME), cancer is the second major cause of death after cardiovascular disorders. The use of advanced materials and drugs in the diagnosis and treatment of cancer has surged with prominent developments in oncology. Radioactive tracer-based imaging is one of the advanced diagnostic methods used to accurately diagnose cancer types, such as prostate cancer, gynecological cancer, and blood-borne cancer. Once injected into the body, these radioactive tracers attach to the cancer-specific sites, accurately diagnosing the cancer type. Tracer also helps determine the cancer development stage, enabling effective treatment and faster recovery in most cases. PET and SPECT are among the nuclear imaging techniques that use gamma emitters for detecting tumors. As the tumor grows, its uptake of the PET and SPECT conjugate increases over time, which improves contrast due to the presence of nuclear imaging agents. This further leads to blood clearance due to which clear diagnostic images can be generated. The most commonly used radioactive tracer for detecting cancer is F-18 fluorodeoxyglucose (18F-FDG), a compound similar to glucose or sugar. Cancer cells are highly active and need more energy, i.e., extra glucose, than normal cells. Imaging devices such as PET or SPECT detect this energy released by FDG to create an image showing the location of a radioactive tracer in the body. This helps determine the location of cancerous cells in the patient's body so that the treatment can be tailored according to the type and stage of cancer. Thus, the increasing use of radioactive tracer in cancer diagnostics is anticipated to drive market expansion during the estimated timeframe.

South & Central America Radioactive Tracer Market Overview

The South & Central America radioactive tracer market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the increasing number of cancer cases, growing government initiatives, and rising research and development for radioactive tracer.

South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Radioactive Tracer Market Segmentation

The South & Central America radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the South & Central America radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.

Based on test type, the South & Central America radioactive tracer market is segmented into PET, SPECT, and others. The PET segment held the largest market share in 2022.

Based on end user, the South & Central America radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.

Based on application, the South & Central America radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.

Based on country, the South & Central America radioactive tracer market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the South & Central America radioactive tracer market share in 2022.

Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, and IBA Radiopharma Solutions are some of the leading players operating in the South & Central America radioactive tracer market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America radioactive tracer market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America radioactive tracer market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America radioactive tracer market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Radioactive Tracer Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Rising Prevalence of Chronic Diseases
    • 4.1.2 Increasing Use of Nuclear Imaging Techniques
  • 4.2 Market Restraints
    • 4.2.1 Short Shelf-Life of Radioactive Tracer
    • 4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
  • 4.3 Market Opportunities
    • 4.3.1 Presence of Emerging Economies and Growing Population
    • 4.3.2 Development of Personalized Radiopharmaceuticals for Targeted Therapies
  • 4.4 Future Trends
    • 4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
  • 4.5 Impact Analysis:

5. Radioactive Tracer Market - South & Central America Market Analysis

  • 5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Tracer Types

  • 6.1 Overview
  • 6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • 6.3 Technetium 99m and TC-97m
    • 6.3.1 Overview
    • 6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Iodine 131
    • 6.4.1 Overview
    • 6.4.2 Iodine 131: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Iron 59
    • 6.5.1 Overview
    • 6.5.2 Iron 59: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Lutetium- 171
    • 6.6.1 Overview
    • 6.6.2 Lutetium- 171: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 RB82 and ammonia N-13
    • 6.7.1 Overview
    • 6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Scandium 46
    • 6.8.1 Overview
    • 6.8.2 Scandium 46: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.9 Seaborgium-269
    • 6.9.1 Overview
    • 6.9.2 Seaborgium-269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.10 Hassium -269
    • 6.10.1 Overview
    • 6.10.2 Hassium -269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.11 Gallium Citrate GA 67
    • 6.11.1 Overview
    • 6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.12 PSMA GA68
    • 6.12.1 Overview
    • 6.12.2 PSMA GA68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.13 FDDNP (F-18) and FDOPA (f-18)
    • 6.13.1 Overview
    • 6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.14 Phosphorus 32 and Chromium -51
    • 6.14.1 Overview
    • 6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.15 Thallium-201
    • 6.15.1 Overview
    • 6.15.2 Thallium-201: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.16 F-18 FDG
    • 6.16.1 Overview
    • 6.16.2 F-18 FDG: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.17 F-18 FAPI
    • 6.17.1 Overview
    • 6.17.2 F-18 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.18 GA 68 FAPI
    • 6.18.1 Overview
    • 6.18.2 GA 68 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.19 F-18 PSMA
    • 6.19.1 Overview
    • 6.19.2 F-18 PSMA: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
    • 6.20.1 Overview
    • 6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.21 Others
    • 6.21.1 Overview
    • 6.21.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 PET
    • 7.3.1 Overview
    • 7.3.2 PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 SPECT
    • 7.4.1 Overview
    • 7.4.2 SPECT: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Application.

  • 8.1 Overview
  • 8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Oncology
    • 8.3.1 Overview
    • 8.3.2 Oncology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Pulmonary
    • 8.4.1 Overview
    • 8.4.2 Pulmonary: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Neurology
    • 8.5.1 Overview
    • 8.5.2 Neurology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cardiology
    • 8.6.1 Overview
    • 8.6.2 Cardiology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Centers: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Radioactive Tracer Market - Country Analysis

  • 10.1 South & Central America Radioactive Tracer Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 South & Central America Radioactive Tracer Market by Country
      • 10.1.2.1 Brazil
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.3 Brazil Radioactive Tracer Market, by Tracer Types
        • 10.1.2.1.4 Brazil Radioactive Tracer Market, by Test Type
        • 10.1.2.1.5 Brazil Radioactive Tracer Market, by Application
        • 10.1.2.1.6 Brazil Radioactive Tracer Market, by End-User
      • 10.1.2.2 Argentina
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Argentina Radioactive Tracer Market, by Tracer Types
        • 10.1.2.2.4 Argentina Radioactive Tracer Market, by Test Type
        • 10.1.2.2.5 Argentina Radioactive Tracer Market, by Application
        • 10.1.2.2.6 Argentina Radioactive Tracer Market, by End-User
      • 10.1.2.3 Rest of South & Central America
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 Rest of South & Central America Radioactive Tracer Market, by Tracer Types
        • 10.1.2.3.4 Rest of South & Central America Radioactive Tracer Market, by Test Type
        • 10.1.2.3.5 Rest of South & Central America Radioactive Tracer Market, by Application
        • 10.1.2.3.6 Rest of South & Central America Radioactive Tracer Market, by End-User

11. Radioactive Tracer Market Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Radioactive Tracer Market, Key Company Profiles

  • 12.1 Rotem Industries Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Invicro LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Cardinal Health Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Newcastle University
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Novartis AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Curium
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 General Electric Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 IBA Radiopharma Solutions
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. South & Central America Radioactive Tracer Market Segmentation
  • Table 2. Principal Radionuclides Used in Radioactive Tracer
  • Table 3. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 4. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Test Type
  • Table 5. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 6. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 7. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 8. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Test Type
  • Table 9. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 10. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 11. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 12. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Test Type
  • Table 13. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 14. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 15. Organic Developments Done by Companies
  • Table 16. Inorganic Developments Done by Companies
  • Table 17. Glossary of Terms, South & Central America Radioactive Tracer Market

List Of Figures

  • Figure 1. South & Central America Radioactive Tracer Market Segmentation, By Country
  • Figure 2. South & Central America Radioactive Tracer Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. South & Central America Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • Figure 6. Technetium 99m and TC-97m: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Iodine 131: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Iron 59: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Lutetium- 171: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. RB82 and ammonia N-13: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Scandium 46: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Seaborgium-269: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Hassium -269: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Gallium Citrate GA 67: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. PSMA GA68: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. FDDNP (F-18) and FDOPA (f-18): South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Phosphorus 32 and Chromium -51: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Thallium-201: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. F-18 FDG: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. F-18 FAPI: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. GA 68 FAPI: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. F-18 PSMA: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. DOTATOC/DOTANOC/DOTATATE Ga 68: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. South & Central America Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 26. PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. SPECT: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. South & Central America Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 30. Oncology: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pulmonary: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Neurology: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Cardiology: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Others: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. South & Central America Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 36. Hospitals and Clinics: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Diagnostic Centers: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Academic and Research Institutes: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Others: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. South & Central America Radioactive Tracer Market, By Geography, 2022 ($Mn)
  • Figure 41. South & Central America Radioactive Tracer Market, By Key Countries, 2022 and 2030 (%)
  • Figure 42. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 44. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)